GENERAL COMMENTS
This manuscript reports on the protocol for a systematic review aiming to compare physiological response to arm versus leg activities in patients with COPD. The manuscript is clearly written and methodology is straightforward. 
This well-written manuscript follows the PRISMA guidelines and will provide information on the physiological responses during arm and leg activities in patients with COPD. The methodology is very nicely described.
I have the following comments: 1) In the introduction, the authors describe that knowledge about the physiological responses may have implications for screening of exercise tolerance and optimal prescription of training interventions in COPD. Please explain further what these implications are.
Please also add to the abstract why it is important to evaluate the potential differences between leg and arm activities.
2) Data extraction: if possible provide more information about the participants (e.g. BMI, comorbidities, medication).
3) Methodological quality assessment will be done by using the 14 most relevant components of the Downs and Black checklist. Please explain further. Why did the authors decide the use 14 components, which components?
VERSION 1 -AUTHOR RESPONSE
Reviewer: 1 1. Abstract. First sentence of the introduction seems to be missing a word ('reduced' everyday activities?)
Response: I'm sorry the sentence was not clear. We have re-worded it (lines 20-22).
2. Study designs. Please clarify whether case-control or cohort (prospective or restrospective) are to be included if they provide physiological responses to arm and leg activities.
Response: It is now written so that any prospective or retrospective study design that provide measurements comparing physiological responses or symptoms to arm versus leg activities will be considered (line 113-117).
3. Participants. Why clinical diagnosis of COPD instead of spirometric definition? Please justify.
Response: Our apologies that this was not clear. The intention was to consider any study stating that the participants had been diagnosed with COPD despite how COPD were defined, assuming that a spirometric definition would have been used. It is now explicitly stated that the studies should define COPD from the guidelines from ATS, ERS, BTS or GOLD (lines 119-122).
4. Study records, selection process. The paragraph is redundant with the following scheme (phases 1, 2, 3). The scheme is much more clear. I suggest to rewrite this part.
Response: We deleted the redundancies with the phases 1, 2 and 3 (lines 193-197).
Data extraction, participants. How are 'drop-outs' to be data extracted if the focus is on crosssectional studies? Please clarify or correct
Response: It is true that drop outs is unlikely in a cross-sectional study, but however, we believe it is possible that there will be participants who do not have results on all included tests, and that this is important to include in the data extraction. Missing values might indicate a systematic bias in the tests used that can be related to physiological responses or symptoms of the individuals with COPD. The wording is changed to missing values on line 239.
6. Please add a section on Discussion about the impact of this review and its strengths and limitations.
Response: A short discussion highlighting aspects from "strengths and limitations" on page 3 and the impact of the review has been added (lines 3012-325).
Reviewer: 2 1) In the introduction, the authors describe that knowledge about the physiological responses may have implications for screening of exercise tolerance and optimal prescription of training interventions in COPD. Please explain further what these implications are.
Response: An example of an implication has been inserted to lines 74-95. In addition, a sentence on the importance of evaluating differences between arm and leg activities have been inserted in the abstract (lines 26-31).
Response: If the studies provide the information we will include BMI, and comorbidities of the participants in the included studies (Lines 238). We did not include medications since results from preliminary searches indicates that it is not expected for medications will be reported in the studies.
Response: Added the components and " The checklist by Downs and Black have been recommended for the assessment of methodological quality for randomized controlled trials and non-randomized trials, including cross-sectional studies.27 The 14 components are appropriate for non-randomized trials and have been used by an earlier review investigating differences between healthy controls and people with COPD regarding physiological responses during arm activities.11"(lines 257-282).
